Learn more of the story of the Moderna Innovation and Technology Centre (MITC) including a global biobank, currently being built at Harwell, Oxfordshire, from Dr Melanie Ivarsson, Senior Vice President and Chief Development Officer at Moderna.
The UK has long been a world leader for clinical trials and life sciences research. But after losing ground post-COVID and post-Brexit, the country has begun to rethink the landscape for clinical trials. As the UK transforms its ecosystem, the UK is undergoing its biggest change in 20 years.
Listen to Dr Ivarsson, to find out why Moderna, with help from the Thames Valley Chamber of Commerce and the Department for Business and Trade, chose Oxfordshire and the UK for a billion-pound research and development programme.
Learn more here
Listen here
